Instadose Pharma Balance Sheet

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2021	FY 2020
Period Ending	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Cash & Equivalents	-	0
Cash & Short-Term Investments	-	0
Total Current Assets	-	0
Total Assets	-	0
Accounts Payable	0.01	0
Accrued Expenses	0.07	-
Other Current Liabilities	0.08	0.08
Total Current Liabilities	0.16	0.08
Total Liabilities	0.16	0.08
Common Stock	0.01	0.01
Additional Paid-In Capital	0.4	0.02
Retained Earnings	-0.57	-0.11
Comprehensive Income & Other	-0	-
Shareholders' Equity	-0.16	-0.08
Total Liabilities & Equity	-	0
Net Cash (Debt)	-	0
Filing Date Shares Outstanding	531.93	75
Total Common Shares Outstanding	75	75
Working Capital	-0.16	-0.08
Book Value Per Share	-0.00	-0.00
Tangible Book Value	-0.16	-0.08
Tangible Book Value Per Share	-0.00	-0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.